Anne Comi

Q: What Schools Are Affiliated With Anne Comi

Anne Comi is affiliated with the following schools: Johns Hopkins University, Harvard University

Anne Comi's AcademicInfluence.com Rankings

Anne Comi

Philosophy

#11840

World Rank

#16370

Historical Rank

#2279

USA Rank

Logic

#8653

World Rank

#10851

Historical Rank

#1452

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Anne Comi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anne Marie Spalding Comi is an American pediatric neurologist specialized in the treatment of Sturge–Weber syndrome. She is a professor of neurology and pediatrics at the Johns Hopkins School of Medicine and director of the Hunter Nelson Sturge-Weber Center at the Kennedy Krieger Institute.

(See a Problem?)

Anne Comi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. (2013) (768)
Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism (1999) (414)
Cerebrospinal fluid and serum markers of inflammation in autism. (2005) (279)
Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results (2018) (142)
Update on Sturge-Weber syndrome: diagnosis, treatment, quantitative measures, and controversies. (2007) (125)
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome (2011) (117)
Practice parameter: evaluation of the child with global developmental delay. (2003) (114)
Topical Review: Pathophysiology of Sturge-Weber Syndrome (2003) (112)
Aspirin Use in Sturge-Weber Syndrome (2013) (91)
Updates and future horizons on the understanding, diagnosis, and treatment of Sturge–Weber syndrome brain involvement (2012) (74)
Current Therapeutic Options in Sturge-Weber Syndrome. (2015) (72)
The actin cytoskeleton mediates the hormonally regulated translocation of type II iodothyronine 5'-deiodinase in astrocytes. (1990) (67)
Dynamic MR perfusion and proton MR spectroscopic imaging in sturge‐weber syndrome: Correlation with neurological symptoms (2006) (67)
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome. (2017) (63)
Survey of Aspirin Use in Sturge-Weber Syndrome (2011) (63)
Advances in Sturge-Weber syndrome (2006) (61)
Ischemia-Induced Neuroinflammation Is Associated with Disrupted Development of Oligodendrocyte Progenitors in a Model of Periventricular Leukomalacia (2013) (55)
Quantitative Analysis of Cerebral Cortical Atrophy and Correlation With Clinical Severity in Unilateral Sturge-Weber Syndrome (2005) (50)
Urban Transport XVII: Urban Transport and the Environment in the 21st Century (2011) (49)
Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group. (1998) (47)
Increased Fibronectin Expression in Sturge-Weber Syndrome Fibroblasts and Brain Tissue (2003) (46)
Encephalofacial Angiomatosis Sparing the Occipital Lobe and Without Facial Nevus: On the Spectrum of Sturge-Weber Syndrome Variants? (2003) (45)
An infantile‐onset, severe, yet sporadic seizure pattern is common in Sturge‐Weber syndrome (2009) (45)
Central hypothyroidism and Sturge-Weber syndrome. (2008) (45)
Growth hormone deficiency in Sturge–Weber syndrome (2006) (44)
Increased choroidal thickness in patients with Sturge-Weber syndrome. (2013) (43)
Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging. (2003) (43)
Neurogenesis and neuronal commitment following ischemia in a new mouse model for neonatal stroke (2008) (43)
Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. (2013) (43)
Gabapentin Neuroprotection and Seizure Suppression in Immature Mouse Brain Ischemia (2008) (43)
Quantitative EEG Asymmetry Correlates with Clinical Severity in Unilateral Sturge‐Weber Syndrome (2007) (42)
A new model of stroke and ischemic seizures in the immature mouse. (2004) (41)
Sturge–Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients (2007) (40)
C-myc and tumour suppressor gene product expression in developing and term human trophoblast. (1994) (39)
A pilot study of the modified Atkins diet for Sturge–Weber syndrome (2010) (39)
Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge–Weber Syndrome (2017) (38)
Chronic brain injury and behavioral impairments in a mouse model of term neonatal strokes (2009) (37)
The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice (2010) (35)
Use of quantitative EEG in infants with port-wine birthmark to assess for Sturge–Weber brain involvement (2009) (32)
Sturge-Weber Syndrome (2011) (31)
Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. (2013) (31)
Neural stem cells reduce brain injury after unilateral carotid ligation. (2008) (29)
Neonatal Stroke in Mice Causes Long-Term Changes in Neuronal Notch-2 Expression That May Contribute to Prolonged Injury (2010) (29)
Self-Reported Treatment Patterns in Patients With Sturge-Weber Syndrome and Migraines (2007) (27)
Sturge-Weber Syndrome (2013) (26)
Oromaxillofacial osseous abnormality in Sturge-Weber syndrome: case report and review of the literature. (2006) (26)
Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 mice (2011) (25)
Sturge-Weber Syndrome: Altered Blood Vessel Fibronectin Expression and Morphology (2005) (24)
EEG evolution in Sturge-Weber syndrome (2014) (24)
Size of Facial Port‐Wine Birthmark May Predict Neurologic Outcome in Sturge‐Weber Syndrome (2017) (23)
Impact of age and strain on ischemic brain injury and seizures after carotid ligation in immature mice (2009) (23)
Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset. (2019) (21)
Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome. (2019) (21)
Neuropsychological Features and Risk Factors in Children With Sturge-Weber Syndrome: Four Case Reports (2010) (21)
Sturge-Weber syndrome associated with other abnormalities: a medical record and literature review. (2005) (21)
Anticonvulsant Efficacy in Sturge-Weber Syndrome. (2016) (21)
Hemiparesis Is a Clinical Correlate of General Adaptive Dysfunction in Children and Adolescents with Sturge-Weber Syndrome (2009) (19)
Behavioral and Psychiatric Features of Sturge-Weber Syndrome (2010) (19)
Case Report of Subdural Hematoma in a Patient With Sturge–Weber Syndrome and Literature Review (2013) (19)
Functional integration of new neurons into hippocampal networks and poststroke comorbidities following neonatal stroke in mice (2010) (18)
Strain Variability, Injury Distribution, and Seizure Onset in a Mouse Model of Stroke in the Immature Brain (2005) (18)
Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome. (2007) (18)
Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research. (2016) (18)
Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease (2015) (17)
Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice (2013) (17)
Corticospinal tract insult alters GABAergic circuitry in the mammalian spinal cord (2013) (16)
Stimulant use in patients with sturge-weber syndrome: safety and efficacy. (2014) (16)
Copper Incorporation into Superoxide Dismutase in Menkes Lymphoblasts* (1996) (16)
Importance of Utilizing a Sensitive Free Thyroxine Assay in Sturge-Weber Syndrome (2013) (15)
Physiatric Findings in Individuals with Sturge-Weber Syndrome (2010) (15)
Dextromethorphan protects male but not female mice with brain ischemia (2006) (15)
Intellectual and adaptive functioning in Sturge-Weber Syndrome (2016) (15)
Transcranial Doppler Ultrasound in Children with Sturge-Weber Syndrome (2008) (13)
Sturge-Weber syndrome: ear, nose, and throat issues and neurologic status. (2010) (13)
Quality of Life in Children With Sturge-Weber Syndrome. (2019) (12)
Systemic injection of CD34(+)-enriched human cord blood cells modulates poststroke neural and glial response in a sex-dependent manner in CD1 mice. (2015) (11)
Urine vascular biomarkers in Sturge–Weber syndrome (2013) (11)
Immature Mouse Unilateral Carotid Ligation Model of Stroke (2005) (11)
Poststroke subgranular and rostral subventricular zone proliferation in a mouse model of neonatal stroke (2009) (11)
Partial Hypopituitarism in Patients With Sturge-Weber Syndrome. (2015) (10)
Sturge-Weber syndrome with cerebellar involvement. (2009) (10)
Identification of a mosaic activating mutation in GNA11 in atypical Sturge-Weber Syndrome. (2020) (10)
Sirolimus Treatment in Sturge-Weber Syndrome. (2020) (9)
Effect of a single application of pulsed dye laser treatment of port-wine birthmarks on intraocular pressure. (2010) (8)
A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge–Weber syndrome (2021) (8)
Cell proliferation and oxidative stress pathways are modified in fibroblasts from Sturge–Weber syndrome patients (2012) (7)
A needle in a haystack: Sturge-Weber syndrome gene discovery. (2013) (7)
Gαq and hyper-phosphorylated ERK expression in Sturge–Weber syndrome leptomeningeal blood vessel endothelial cells (2018) (6)
Preliminary reliability and validity of a battery for assessing functional skills in children with Sturge-Weber syndrome (2014) (5)
Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. (2021) (5)
Reliability and Clinical Correlation of Transcranial Doppler Ultrasound in Sturge-Weber Syndrome. (2017) (5)
The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder (2021) (4)
An overview of current and future treatment options for Sturge–Weber syndrome (2014) (3)
Quantitative EEG improves prediction of Sturge-Weber syndrome in infants with port-wine birthmark (2021) (3)
Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome. (2021) (3)
Atypical Intracerebral Developmental Venous Anomalies in Sturge-Weber Syndrome: A Case Series and Review of Literature. (2019) (3)
RSRC1 loss-of-function variants cause mild to moderate autosomal recessive intellectual disability (2020) (3)
Stroke: Neonate vs. Adult (2009) (2)
Suicide Screening in Sturge-Weber Syndrome: An Important Issue in Need of Further Study. (2020) (2)
Direct Radiative Effect and Heating Rate of black carbon aerosol: high time resolution measurements and source-identified forcing effects (2016) (1)
Correction: Systemic Injection of CD34+ -Enriched Human Cord Blood Cells Modulates Poststroke Neural and Glial Response in a Sex-Dependent Manner in CD1 Mice (Stem Cells and Development (2015) 24, 1 (51-66)) (2015) (1)
Characterising the U9 Milan background site that links together radiation and pollution measurements (2015) (1)
Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber (2022) (1)
Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge–Weber syndrome (2023) (1)
Vitamin D and Neurological Status in Sturge-Weber Syndrome (2021) (1)
Neuroprotection for Ischemic Injury in the Immature Brain (2005) (1)
Acknowledgement to Referees 2013 (2014) (0)
Anaesthesia recommendations for patients suffering From: Sturge-Weber syndrome (2018) (0)
Leptomeningeal phosphorylated ERK expression and urine vascular biomarkers in Sturge-Weber syndrome (2014) (0)
Brain Vascular MalformaƟon ConsorƟum: Overview, Progress, and Future DirecƟons (2013) (0)
growth factor mRNA and protein in adult mouse brain Prolonged hypoxia increases vascular endothelial (2015) (0)
Predictive Value of Size of Port-Wine Stains in Sturge-Weber Syndrome (S35.007) (2015) (0)
Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome. (2022) (0)
Clinical Cases in Neurology From Johns Hopkins - Case 4: Just a bruise? (2003) (0)
syndromehormone deficiency in Sturge-Weber (2006) (0)
Brain Involvement in Sturge-Weber (2009) (0)
eP250: Molecular findings in patients with atypical Sturge-Weber syndrome (2022) (0)
Reduction in school individualized education program (IEP) services during the COVID-19 pandemic (2022) (0)
2 – Developmental malformations (2016) (0)
Pandemic intake questionnaire to improve quality, effectiveness, and efficiency of outpatient neurologic and developmental care at the Kennedy Krieger institute during the COVID-19 pandemic (2022) (0)
The use of microarrays to study childhood developmental brain disorders (2002) (0)
List of contributors (2020) (0)
ANKLE2 ‐related microcephaly: A variable microcephaly syndrome resembling Zika infection (2022) (0)
C-myc and Tumour Suppressor Gene Product Expression in Developing and Human Trophoblast Term (1994) (0)
You Can Manage Sturge-Weber Syndrome (2007) (0)
Contributing Reviewers in 2017 (2018) (0)
Team Effort Needed to Treat Sturge-Weber (2008) (0)
Updates on Sturge-Weber Syndrome (2022) (0)
Poster 229: Physiatric Experience with Sturge‐Weber Syndrome: A Case Series of 30 Patients (2009) (0)
Short reports Macrocryosectioning of the prostate: a simple technique (2001) (0)
Chapter 81 – Sturge–Weber Syndrome (2015) (0)

This paper list is powered by the following services:

Other Resources About Anne Comi

en.wikipedia.org

What Schools Are Affiliated With Anne Comi?

Anne Comi is affiliated with the following schools: